These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
239 related articles for article (PubMed ID: 23690449)
1. Common and rare von Willebrand factor (VWF) coding variants, VWF levels, and factor VIII levels in African Americans: the NHLBI Exome Sequencing Project. Johnsen JM; Auer PL; Morrison AC; Jiao S; Wei P; Haessler J; Fox K; McGee SR; Smith JD; Carlson CS; Smith N; Boerwinkle E; Kooperberg C; Nickerson DA; Rich SS; Green D; Peters U; Cushman M; Reiner AP; Blood; 2013 Jul; 122(4):590-7. PubMed ID: 23690449 [TBL] [Abstract][Full Text] [Related]
2. Gene-centric approach identifies new and known loci for FVIII activity and VWF antigen levels in European Americans and African Americans. Tang W; Cushman M; Green D; Rich SS; Lange LA; Yang Q; Tracy RP; Tofler GH; Basu S; Wilson JG; Keating BJ; Weng LC; Taylor HA; Jacobs DR; Delaney JA; Palmer CD; Young T; Pankow JS; O'Donnell CJ; Smith NL; Reiner AP; Folsom AR Am J Hematol; 2015 Jun; 90(6):534-40. PubMed ID: 25779970 [TBL] [Abstract][Full Text] [Related]
3. Diagnosis of von Willebrand disease type 2N: a simplified method for measurement of factor VIII binding to von Willebrand factor. Miller CH; Kelley L; Green D Am J Hematol; 1998 Aug; 58(4):311-8. PubMed ID: 9692396 [TBL] [Abstract][Full Text] [Related]
4. A variational Bayes discrete mixture test for rare variant association. Logsdon BA; Dai JY; Auer PL; Johnsen JM; Ganesh SK; Smith NL; Wilson JG; Tracy RP; Lange LA; Jiao S; Rich SS; Lettre G; Carlson CS; Jackson RD; O'Donnell CJ; Wurfel MM; Nickerson DA; Tang H; Reiner AP; Kooperberg C; Genet Epidemiol; 2014 Jan; 38(1):21-30. PubMed ID: 24482836 [TBL] [Abstract][Full Text] [Related]
5. Unraveling the Influence of Common von Willebrand factor variants on von Willebrand Disease Phenotype: An Exploratory Study on the Molecular and Clinical Profile of von Willebrand Disease in Spain Cohort. Borràs N; Garcia-Martínez I; Batlle J; Pérez-Rodríguez A; Parra R; Altisent C; López-Fernández MF; Costa Pinto J; Batlle-López F; Cid AR; Bonanad S; Cabrera N; Moret A; Mingot-Castellano ME; Navarro N; Pérez-Montes R; Marcellini S; Moreto A; Herrero S; Soto I; Fernández-Mosteirín N; Jiménez-Yuste V; Alonso N; de Andrés-Jacob A; Fontanes E; Campos R; Paloma MJ; Bermejo N; Berrueco R; Mateo J; Arribalzaga K; Marco P; Palomo Á; Castro Quismondo N; Iñigo B; Del Mar Nieto M; Vidal R; Martínez MP; Aguinaco R; Tenorio M; Ferreiro M; García-Frade J; Rodríguez-Huerta AM; Cuesta J; Rodríguez-González R; García-Candel F; Dobón M; Aguilar C; Corrales I; Vidal F Thromb Haemost; 2020 Mar; 120(3):437-448. PubMed ID: 32135566 [TBL] [Abstract][Full Text] [Related]
6. Correlation between von Willebrand factor antigen, von Willebrand factor ristocetin cofactor activity and factor VIII activity in plasma. Lippi G; Franchini M; Salvagno GL; Montagnana M; Poli G; Guidi GC J Thromb Thrombolysis; 2008 Oct; 26(2):150-3. PubMed ID: 17786534 [TBL] [Abstract][Full Text] [Related]
7. Aging and ABO blood type influence von Willebrand factor and factor VIII levels through interrelated mechanisms. Albánez S; Ogiwara K; Michels A; Hopman W; Grabell J; James P; Lillicrap D J Thromb Haemost; 2016 May; 14(5):953-63. PubMed ID: 26875505 [TBL] [Abstract][Full Text] [Related]
8. Next-generation sequencing of von Willebrand factor and coagulation factor VIII genes: a cross-sectional study in Croatian adult patients diagnosed with von Willebrand disease. Lapić I; Radić Antolic M; Boban A; Coen Herak D; Rogić D; Zadro R Croat Med J; 2022 Apr; 63(2):166-175. PubMed ID: 35505650 [TBL] [Abstract][Full Text] [Related]
9. Influence of single nucleotide polymorphisms in factor VIII and von Willebrand factor genes on plasma factor VIII activity: the ARIC Study. Campos M; Buchanan A; Yu F; Barbalic M; Xiao Y; Chambless LE; Wu KK; Folsom AR; Boerwinkle E; Dong JF Blood; 2012 Feb; 119(8):1929-34. PubMed ID: 22219226 [TBL] [Abstract][Full Text] [Related]
10. Genetic Variants Identified by Whole Exome Sequencing in a Large Italian Family with High Plasma Levels of Factor VIII and Von Willebrand Factor. Spena S; Cairo A; Gianniello F; Pappalardo E; Mortarino M; Garagiola I; Martinelli I; Peyvandi F Int J Mol Sci; 2023 Sep; 24(18):. PubMed ID: 37762470 [TBL] [Abstract][Full Text] [Related]
11. Whole-exome sequencing of 14 389 individuals from the ESP and CHARGE consortia identifies novel rare variation associated with hemostatic factors. Pankratz N; Wei P; Brody JA; Chen MH; de Vries PS; Huffman JE; Stimson MR; Auer PL; Boerwinkle E; Cushman M; de Maat MPM; Folsom AR; Franco OH; Gibbs RA; Haagenson KK; Hofman A; Johnsen JM; Kovar CL; Kraaij R; McKnight B; Metcalf GA; Muzny D; Psaty BM; Tang W; Uitterlinden AG; van Rooij JGJ; Dehghan A; O'Donnell CJ; Reiner AP; Morrison AC; Smith NL Hum Mol Genet; 2022 Sep; 31(18):3120-3132. PubMed ID: 35552711 [TBL] [Abstract][Full Text] [Related]
12. High levels of coagulation factors and venous thrombosis risk: strongest association for factor VIII and von Willebrand factor. Rietveld IM; Lijfering WM; le Cessie S; Bos MHA; Rosendaal FR; Reitsma PH; Cannegieter SC J Thromb Haemost; 2019 Jan; 17(1):99-109. PubMed ID: 30471183 [TBL] [Abstract][Full Text] [Related]
13. The evaluation of factor VIII binding activity of von Willebrand factor by means of an ELISA method: significance and practical implications. Casonato A; Pontara E; Zerbinati P; Zucchetto A; Girolami A Am J Clin Pathol; 1998 Mar; 109(3):347-52. PubMed ID: 9495210 [TBL] [Abstract][Full Text] [Related]
14. Type 2N von Willebrand disease: Characterization and diagnostic difficulties. Casonato A; Galletta E; Sarolo L; Daidone V Haemophilia; 2018 Jan; 24(1):134-140. PubMed ID: 29115006 [TBL] [Abstract][Full Text] [Related]
15. VWF sequence variants: a data goldmine. Goodeve AC Blood; 2013 Jul; 122(4):471-3. PubMed ID: 23886775 [No Abstract] [Full Text] [Related]
16. Coagulation factor VIII: Relationship to cardiovascular disease risk and whole genome sequence and epigenome-wide analysis in African Americans. Raffield LM; Lu AT; Szeto MD; Little A; Grinde KE; Shaw J; Auer PL; Cushman M; Horvath S; Irvin MR; Lange EM; Lange LA; Nickerson DA; Thornton TA; Wilson JG; Wheeler MM; ; Zakai NA; Reiner AP J Thromb Haemost; 2020 Jun; 18(6):1335-1347. PubMed ID: 31985870 [TBL] [Abstract][Full Text] [Related]
17. Reevaluation of von Willebrand disease diagnosis in a Croatian paediatric cohort combining bleeding scores, phenotypic laboratory assays and next generation sequencing: a pilot study. Lapić I; Radić Antolic M; Dejanović Bekić S; Coen-Herak D; Bilić E; Rogić D; Zadro R Biochem Med (Zagreb); 2022 Feb; 32(1):010707. PubMed ID: 35210927 [TBL] [Abstract][Full Text] [Related]
18. Cerebral venous thrombosis and plasma concentrations of factor VIII and von Willebrand factor: a case control study. Bugnicourt JM; Roussel B; Tramier B; Lamy C; Godefroy O J Neurol Neurosurg Psychiatry; 2007 Jul; 78(7):699-701. PubMed ID: 17189302 [TBL] [Abstract][Full Text] [Related]
19. Bleeding prophylaxis for major surgery in patients with type 2 von Willebrand disease with an intermediate purity factor VIII-von Willebrand factor concentrate (Haemate-P). Michiels JJ; Berneman ZN; van der Planken M; Schroyens W; Budde U; van Vliet HH Blood Coagul Fibrinolysis; 2004 Jun; 15(4):323-30. PubMed ID: 15166918 [TBL] [Abstract][Full Text] [Related]
20. Rise of levels of von Willebrand factor and factor VIII with age: Role of genetic and acquired risk factors. Biguzzi E; Castelli F; Lijfering WM; Cannegieter SC; Eikenboom J; Rosendaal FR; van Hylckama Vlieg A Thromb Res; 2021 Jan; 197():172-178. PubMed ID: 33221577 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]